Filing Flows › Champions Oncology (CSBR) › Pharmacology services revenue
Champions Oncology (CSBR) Pharmacology services revenue by quarter
Champions Oncology's Pharmacology services revenue was $14.2M in Q1 FY27 (first quarter fiscal 2027), +7% from Q4 FY26. Over the last 6 quarters it ranged from $11.7M (Q3 FY25) to $16.2M (Q3 FY26).
| Quarter | Pharmacology services revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $14.2M | +7% | +7% |
| Q4 FY26 | $13.2M | -18% | — |
| Q3 FY26 | $16.2M | +11% | +39% |
| Q2 FY26 | $14.5M | +10% | — |
| Q1 FY26 | $13.2M | +13% | — |
| Q3 FY25 | $11.7M | — | — |
Q1 FY27 at a glance
Champions Oncology, Q1 FY27: revenue $15.2M (+9% year over year), operating margin -2.7%, net loss $426K, operating cash flow −$492K. The chart follows the revenue to costs, profit and cash.
Questions
What is Champions Oncology's Pharmacology services revenue?
Champions Oncology's Pharmacology services revenue was $14.2M in Q1 FY27 (first quarter fiscal 2027), +7% from Q4 FY26.
How has Champions Oncology's Pharmacology services revenue changed?
Over the last 6 quarters it ranged from $11.7M (Q3 FY25) to $16.2M (Q3 FY26).